U.S. drug cost effectiveness organization Institute for Clinical and Economic Review routinely clashes with pharma by arguing that new drug prices are too high. Now, the group plans to spotlight price hikes on old drugs that aren't supported by new clinic
The EC has opened a formal investigation into concerns that Aspen Pharma has engaged in excessive pricing concerning five life-saving cancer medicines. The Commission will investigate whether Aspen has abused a dominant market position in breach of EU ant
With 2017 having seen some of the first corrugated cardboard price hikes to hit the sector for almost four years, Antalis Packaging says that it is now more important than ever for companies to be watchful on their corrugated box specification and quality